Pancreatic

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
16994P
Open Label Phase II study on Glufosfamide administered as a 60 minute infusion every 3 weeks in advanced pancreatic cancer:EORTC study 16994P
40984
Randomized phase II study of docetaxel/gemcitabine Vs docetaxel/cisplatin in metastatic or locoregionally advanced pancreatic carcinoma
05962
Infusional 5-Fluorouracil with or without cisplatin and with or without chronomodulation against locally-advanced or metastatic pancreatic cancer. A multicenter randomized Phase III trial.
40961
Phase II trial. Weekly high dose 5-FU and Folinic Acid in metastatic pancreatic carcinoma.
40924
Randomized phase II-III clinical trial of Cisplatin + 5-fluorouracil vs Cisplatin + 5-fluorouracil with alpha-Interferon in metastatic pancreatic cancer
40891
Randomized phase III trial of radiotherapy and 5-FU treatment after curative resection for cancer of the pancreas and periampullary region
16871P
Phase II trial of DuP 785 (NSC 368390) in patients with adenocarcinoma of the pancreas
40873
Phase II clinical trial of epirubicin and cisplatin (EP) in combination with a split cause radiotherapy plus 5-Fluorouracil in locally advanced unresectable pancreatic cancer.
40013
Randomised phase II/III study comparing gemcitabine followed by gemcitabine plus concomitant radiation (50.4 Gy) versus gemcitabine alone after curative pancreaticoduodenectomy for pancreatic head cancer
16923P
Phase II trial with CPT-11 in patients with pancreatic carcinoma

Back to Site-list